Document:

Amendment No. 4 to the Credit Agreement

 Exhibit 10.1 
 EXECUTION VERSION 
 AMENDMENT NO. 4 

This Amendment No. 4, dated as of August 23, 2012 (this “Amendment”), to that certain Credit Agreement, dated
as of August 7, 2007 (as amended by Amendment No. 1, dated as of November 21, 2008, Amendment No. 2 and Consent, dated as of May 13, 2011, and Amendment No. 3, dated as of March 9, 2012, the “Credit
Agreement”), among ALLISON TRANSMISSION HOLDINGS, INC., a Delaware corporation (“Holdings”), ALLISON TRANSMISSION, INC., a Delaware corporation (the “Borrower”), the several banks and other financial
institutions or entities from time to time parties thereto (the “Lenders”), CITICORP NORTH AMERICA, INC., as Administrative Agent, and the other agents and arrangers parties thereto, is entered into by and among Holdings, the
Borrower, the Agents and the Initial Term B-3 Lenders (as defined below). Capitalized terms used herein but not defined herein are used as defined in the Credit Agreement. 
 W I T N E S S E T H: 

WHEREAS, the Borrower has hereby notified the Administrative Agent and each Term Lender that it intends to incur Specified
Refinancing Debt pursuant to Section 2.26(b) of the Credit Agreement in order to refinance up to $850,000,000 of the Term B-1 Loans; 
 WHEREAS, pursuant to Section 2.26(c) of the Credit Agreement, the Borrower may establish an additional Tranche of Specified Refinancing Debt by, among other things, entering into this
Amendment pursuant to the terms and conditions of the Credit Agreement with Term Lenders agreeing to provide such additional Tranche of Specified Refinancing Debt (each such Term Lender agreeing to provide Term B-3 Loans (as defined below) and any
assignees thereof, are referred to herein as “Term B-3 Lenders); 
 WHEREAS, the Borrower has
requested that the initial Term B-3 Lenders party hereto (each, an “Initial Term B-3 Lender”) extend credit to the Borrower in the form of Term Loans in an aggregate principal amount of $850,000,000 (the “Term B-3
Loans”; all of the Term B-3 Loans shall constitute a new Tranche of Specified Refinancing Debt referred to herein as the “Term B-3 Facility”); and 
 WHEREAS, each Initial Term B-3 Lender has indicated its willingness to lend such Term B-3 Loans in the aggregate amount specified on its signature page to this Amendment on the terms and
subject to the conditions herein. 
 NOW, THEREFORE, in consideration of the premises and
agreements, provisions and covenants herein contained, the parties hereto agree as follows: 
 SECTION 1. TERM B-3 FACILITY.

 1.1 Term B-3 Loans. Each Initial Term B-3 Lender hereby agrees to make Term B-3 Loans in the aggregate
amount specified on such Initial Term B-3 Lender’s signature page to this Amendment on the Fourth Amendment Effective Date (as defined in Section 2 below). Pursuant to Section 2.26 of the Credit Agreement, the Term B-3 Loans shall
have the terms set forth in this Amendment and in the Credit Agreement (as amended by this Amendment). 
 1.2 Applicable
Margin; LIBO Rate. The Term B-3 Loans may from time to time be LIBO Rate Loans or Base Rate Loans, as determined by the Borrower and notified to the Administrative Agent in accordance with Sections 2.13 of the Credit Agreement. In the case
of Term B-3 Loans that are LIBO 

 
Rate Loans, (a) the Applicable Margin shall mean a percentage per annum equal to (i) if the Total Leverage Ratio is greater than 3.25 to 1.00, 3.25% and (ii) if the Total Leverage
Ratio is less than or equal to 3.25 to 1.00, 3.0%, and (b) the LIBO Rate shall at no time be less than 1.0% per annum. In the case of Term B-3 Loans that are Base Rate Loans, (x) the Applicable Margin shall mean a percentage per annum
equal to (i) if the Total Leverage Ratio is greater than 3.25 to 1.00, 2.25% and (ii) if the Total Leverage Ratio is less than or equal to 3.25 to 1.00, 2.0%, and (y) the Base Rate shall at no time be less than 2.0% per annum.
Changes in the Applicable Margin with respect to the Term B-3 Loans resulting from changes in the Total Leverage Ratio shall become effective on the date on which financial statements are delivered to the Administrative Agent pursuant to
Section 6.1 of the Credit Agreement and shall remain in effect until the next change to be effected pursuant to this Section 1.2; provided, that from the Fourth Amendment Effective Date until the next change in the Applicable
Margin, the Applicable Margin with respect to the Term B-3 Loans shall be 3.25% with respect to LIBO Rate Loans and 2.25% with respect to Base Rate Loans. If any financial statements referred to above are not delivered within the time periods
specified in Section 6.1 of the Credit Agreement, then, at the option of (and upon the delivery of notice (telephonic or otherwise) by) the Administrative Agent or the Majority Term B-3 Facility Lenders (as defined below), until such financial
statements are delivered, the Total Leverage Ratio as at the end of the fiscal period that would have been covered thereby shall for the purposes of this Section 1.2 be deemed to be greater than 3.25 to 1.00. In addition, at all times while an
Event of Default set forth in Section 8(a) or 8(f) of the Credit Agreement shall have occurred and be continuing, the Total Leverage Ratio shall for the purposes of this Section 1.2 be deemed to be greater than 3.25 to 1.00. 

1.3 Amortization and Maturity Date. The Term B-3 Loans of each Term B-3 Lender shall be payable in equal consecutive
quarterly installments on the last Business Day of each of December, March, June and September, commencing on the last Business Day of September 2012, in an amount equal to one quarter of one percent (0.25%) of the aggregate amount of Term B-3 Loans
made on the Fourth Amendment Effective Date (as adjusted to reflect any prepayments thereof (other than any Discounted Voluntary Prepayment)), with the remaining balance of Term B-3 Loans payable on August 23, 2019 (the “Term B-3
Maturity Date”). 
 1.4 Mandatory Prepayments. The Term B-3 Loans shall be subject to mandatory
prepayments on the same terms as Term B-1 Loans as set forth in Section 2.12 of the Credit Agreement and any such prepayments shall be made ratably among the Term B-1 Loans, Term B-2 Loans and Term B-3 Loans (other than with respect to any
Specified Refinancing Debt incurred to refinance any Tranche). Pursuant to Section 2.18(b) of the Credit Agreement, any such mandatory prepayment on account of the Term B-3 Loans pursuant to Section 2.12 shall be applied to the remaining
installments of the Term B-3 Loans as directed by the Borrower. 
 1.5 Optional Prepayments. The Term B-3 Loans
may be optionally prepaid on the same terms as Term B-1 Loans as set forth in Section 2.11 of the Credit Agreement; provided, that optional prepayment shall be applied ratably among the Term B-1 Loans, Term B-2 Loans and Term B-3 Loans;
provided, however, that the Term B-1 Loans and/or the Term B-2 Loans may be optionally prepaid without a ratable prepayment of the Term B-3 Loans. As set forth in Section 2.18(b) of the Credit Agreement, optional prepayments
of any Term B-3 Loans shall be applied to the remaining installments of the Term B-3 Facility as specified by the Borrower. 

1.6 Use of Proceeds. The proceeds of the Term B-3 Loans shall be applied toward the payment of (a) the aggregate
outstanding principal amount of the Term B-1 Loans and (b) fees, expenses and original issue discount payable in connection with the Term B-3 Loans. 
 1.7 Credit Agreement Governs. Effective as of the Fourth Amendment Effective Date, except as set forth in this Amendment, (a) the Term B-3 Loans shall have identical terms as the Term
B-1 

  
 2 

 
Loans and shall otherwise be subject to the provisions, including any provisions restricting the rights, or regarding the obligations, of the Loan Parties or any provisions regarding the rights
of the Term Lenders, of the Credit Agreement and the other Loan Documents, (b) the Term B-3 Loans shall be Specified Refinancing Debt and Specified Refinancing Term Loans under the Credit Agreement, (c) this Amendment shall be a
Refinancing Amendment under the Credit Agreement, (d) each reference in the Credit Agreement to (i) “Facility” shall be deemed to include the Term B-3 Facility and (ii) “Majority Facility Lenders”, with respect to
the Term B-3 Facility, shall be deemed to include the holders of more than 50% of the aggregate unpaid principal amount of the Term B-3 Loans outstanding under such Facility, (e) the definitions of “Required Prepayment Lenders” and
“Term Loans” in the Credit Agreement are hereby amended and restated in their entirety to read as follows below and (f) the definitions of “Majority Term B-3 Facility Lenders”, “Term B-3 Facility”, “Term B-3
Loans”, “Term B-3 Maturity Date” and “Fourth Amendment” as follows below shall hereby be inserted into Section 1.1 of the Credit Agreement in the correct alphabetical order: 

“Required Prepayment Lenders”: the holders of more than 50% of the aggregate unpaid principal amount of the Term Loans
outstanding under the Term B-1 Facility, the Term B-2 Facility and the Term B-3 Facility. 
 “Term Loans”: the
Term B-1 Loans, the Term B-2 Loans and the Term B-3 Loans. 
 “All-In Yield: as to any Indebtedness, the yield
thereon, whether in the form of interest rate, margin (after giving effect to any floors), OID, up-front fees (with such increased amount being equated to interest margins for purposes of determining any increase to the applicable rate under any
Facility), or otherwise; provided, that OID and up-front fees shall be equated to interest rate assuming a 4-year life to maturity; and provided, further, that “All-In Yield” shall not include arrangement fees or
underwriting or similar fees paid to arrangers for such Indebtedness. 
 “Majority Term B-3 Facility Lenders”:
the Majority Facility Lenders in respect of the Term B-3 Facility. 
 “Term B-3 Facility”: as defined in the
Fourth Amendment. 
 “Term B-3 Lenders”: as defined in the Fourth Amendment 

“Term B-3 Loan Repricing Transaction”: (a) any prepayment or repayment of Term B-3 Loans with the proceeds of, or
any conversion of Term B-3 Loans into, any new or replacement tranche of term loans or Indebtedness incurred for the primary purpose of prepaying, repaying or replacing the Term B-3 Loans and bearing interest with an All-In Yield less than
(i) if the Applicable Margin in effect with respect to Term B-3 Loans at the time of such prepayment or repayment of Term B-3 Loans is 3.25%, 4.50% and (ii) if the Applicable Margin in effect with respect to Term B-3 Loans at the time of
such prepayment or repayment of Term B-3 Loans is 3.0%, 4.25% and (b) any amendment to the Term B-3 Loans the primary purpose of which is to reduce the All-In Yield applicable to such Term B-3 Loans; provided, that in no event shall any
prepayment, repayment or replacement of Term B-3 Loans in connection with a Change of Control constitute a Term B-3 Loan Repricing Transaction. 
 “Term B-3 Loans”: as defined in the Fourth Amendment. 

“Term B-3 Maturity Date”: as defined in the Fourth Amendment. 

  
 3 

 “Fourth Amendment”: Amendment No. 4 to the Credit Agreement, dated as
of August 23, 2012, among Holdings, the Borrower, the Administrative Agent, the Collateral Agent and the Lenders party thereto. 
 1.8 Credit Agreement Amendments. Effective as of the Fourth Amendment Effective Date, 
 (a) Section 2.11(b)(i) of the Credit Agreement is hereby amended by replacing “Term B-2 Maturity Date” in the first sentence thereof with “Term B-3 Maturity Date”; 

(b) The following Section 2.28 shall be inserted into the Credit Agreement: 

“Section 2.28 Term B-3 Loan Repricing Transaction. Notwithstanding anything to the contrary in this Agreement, in the event
that, on or prior to the first anniversary of the Fourth Amendment Effective Date, the Borrower (a) makes any prepayment of Term B-3 Loans constituting a Term B-3 Loan Repricing Transaction or (b) effects any amendment of this Agreement
constituting a Term B-3 Loan Repricing Transaction, the Borrower shall pay to the Administrative Agent, for the ratable account of each of the applicable Term B-3 Lenders, (x) in the case of clause (a), a prepayment premium of 1.00% of the
amount of the Term B-3 Loans being prepaid and (y) in the case of clause (b), a payment equal to 1.00% of the aggregate amount of the applicable Term B-3 Loans outstanding immediately prior to such amendment.”; 

(c) Section 6.1 of the Credit Agreement is amended by inserting the following provision after the last sentence in such Section:

 “After the Term B-2 Maturity Date, the Borrower may elect to deliver financial statements of Holdings and its
consolidated Restricted Subsidiaries in lieu of financial statements of the Borrower and its consolidated Subsidiaries in satisfaction of the requirements of Section 6.1(a) and 6.1(b) commencing on any period following the Term B-2 Maturity
Date and for each period thereafter; provided, that concurrently with the delivery of any such financial statements of Holdings and its consolidated Restricted Subsidiaries, the Borrower shall deliver a certificate of a Responsible Officer on
behalf of the Borrower showing adjustments attributable solely to Holdings and its consolidated Restricted Subsidiaries (other than the Borrower and its consolidated Subsidiaries).” 

(d) Section 10.1 of the Credit Agreement is amended by amending and restating the parenthetical in clause (i) of the proviso
thereof to read as follows: 
 “(except (A) in connection with the waiver of applicability of any post-default increase in interest
rates (which waiver shall be effective (w) as to the Revolving Facility, with the consent of the Majority Revolving Facility Lenders, (x) as to the Term B-1 Facility, with the consent of the Majority Term B-1 Facility Lenders, (y) as
to the Term B-2 Facility, with the consent of the Majority Term B-2 Facility Lenders and (z) as to the Term B-3 Facility, with the consent of the Majority Term B-3 Facility Lenders) and (B) that any amendment or modification of defined
terms used in the financial ratios in this Agreement shall not constitute a reduction in the rate of interest or fees for purposes of this clause (i))”; and 
 (e) Section 10.6(b)(ii)(A) of the Credit Agreement is amended by replacing “Term Facility” therein with “Term B-1 Facility, Term B-2 Facility or Term B-3 Facility”. 

  
 4 

 SECTION 2. CONDITIONS PRECEDENT 

This Amendment shall become effective as of the date (the “Fourth Amendment Effective Date”) on which each of the
following conditions precedent shall have been satisfied or duly waived: 
 2.1 Certain
Documents. The Administrative Agent shall have received each of the following, in form and substance satisfactory to the Administrative Agent: 
 (a) this Amendment, duly executed by each of the Borrower, Holdings, the Administrative Agent, and each Initial Term B-3 Lender; 

(b) a solvency certificate signed by the chief financial officer on behalf of the Borrower, substantially in the form of Exhibit G
of the Credit Agreement; 
 (c) a closing certificate of each Loan Party, substantially in the form of Exhibit A
hereto, with appropriate insertions and attachments; and 
 (d) an executed legal opinion of Latham & Watkins LLP,
counsel to the Loan Parties, in form and substance reasonably acceptable to the Administrative Agent. 
 2.2 Fees and
Expenses.  
 (a) The Borrower shall have paid in full on the Fourth Amendment Effective Date to
each Initial Term B-3 Lender, as fee compensation for the making of the Term B-3 Loans, a fee (the “Upfront Fee”) in an amount equal to 1.00% of the stated principal amount of the Term B-3 Loan made by such Initial Term B-3 Lender
on the Fourth Amendment Effective Date (which may be netted from the proceeds of the Term B-3 Loans). 
 (b) All fees and
reimbursable expenses that have been invoiced as of the Fourth Amendment Effective Date that are due and payable to any Person under any engagement letter entered into in connection with this Amendment shall have been paid in full in immediately
available funds. 
 2.3 Representations and Warranties. Each of the representations and
warranties contained in Section 3 below shall be true and correct. 
 2.4 Minimum Refinancing Condition. The
aggregate principal amount of the Term B-3 Loans shall not be less than $15,000,000. 
 2.5 USA Patriot Act. The
Initial Term B-3 Lenders shall have received from each of the Loan Parties documentation and other information required by regulatory authorities under applicable “know your customer” and anti-money laundering rules and regulations,
including, without limitation, the USA Patriot Act, to the extent such documentation or other information has been requested in writing at least five (5) Business Days prior to Fourth Amendment Effective Date. 

SECTION 3. REPRESENTATIONS AND WARRANTIES 
 Each of Holdings and the Borrower, on behalf of itself and each Loan Party, hereby represents and warrants to the Agents and each Lender, with respect to all Loan Parties, as follows: 

3.1 Incorporation of Representations and Warranties from Loan Documents. After giving effect to this Amendment, each of the
representations and warranties in the Credit Agreement and 

  
 5 

 
in the other Loan Documents are true and correct in all material respects (except to the extent that such representation or warranty is qualified as to materiality, in which case it shall be true
and correct in all respects) on and as of the date hereof as though made on and as of such date, except to the extent that any such representation or warranty expressly relates to an earlier date; 

3.2 Corporate Power and Authority. Each of Holdings and the Borrower has taken all necessary action to authorize the
execution, delivery and performance of this Amendment, this Amendment has been duly executed and delivered by each of Holdings and the Borrower, and this Amendment is the legal, valid and binding obligation of each of Holdings and the Borrower,
enforceable against it in accordance with its terms, except as enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or similar laws affecting the enforcement of creditors’ rights generally and by
general equitable principles; and 
 3.3 Absence of Default. Neither Holdings, the Borrower nor any of its
Restricted Subsidiaries is in violation of any Requirement of Law or Contractual Obligation that could reasonably be expected to have a Material Adverse Effect. At the time of and immediately after giving effect to this Amendment, no Default or
Event of Default has occurred and is continuing. 
 SECTION 4. MISCELLANEOUS 

4.1 Reference to and Effect on the Loan Documents. 
 (a) As of the Fourth Amendment Effective Date, each reference in the Credit Agreement to “this Agreement,” “hereunder,” “hereof,”
“herein,” or words of like import, and each reference in the other Loan Documents to the Credit Agreement (including, without limitation, by means of words like “thereunder”, “thereof” and words of
like import), shall mean and be a reference to the Credit Agreement as amended by this Amendment. 
 (b) Except as expressly
amended hereby, all of the terms and provisions of the Credit Agreement and all other Loan Documents are and shall remain in full force and effect and are hereby ratified and confirmed. 

(c) The execution, delivery and effectiveness of this Amendment shall not, except as expressly provided herein, operate as a waiver of
any right, power or remedy of the Administrative Agent, any Lender or any Issuing Lender under the Credit Agreement or any Loan Document, or constitute a waiver or amendment of any other provision of the Credit Agreement or any Loan Document (as
amended hereby) except as and to the extent expressly set forth herein. 
 4.2 Costs and Expenses. The Borrower
agrees to reimburse the Administrative Agent for its costs and expenses in connection with this Amendment (and the other Loan Documents delivered in connection herewith) as provided in Section 10.5 of the Credit Agreement. 

4.3 Reaffirmation. Each of Holdings and the Borrower hereby confirms that the guaranties, security interests and liens
granted pursuant to the Loan Documents continue to guarantee and secure the Obligations as set forth in the Loan Documents and that such guaranties, security interests and liens remain in full force and effect. Each of Holdings and the Borrower
confirms and ratifies its obligations under each of the Loan Documents executed by it after giving effect to this Amendment. 

4.4 Counterparts. This Amendment may be executed in any number of counterparts and by different parties hereto in separate
counterparts, each of which when so executed shall be deemed to be an original and all of which taken together shall constitute one and the same agreement. Receipt by the Administrative Agent of a facsimile copy of an executed signature page hereof
shall constitute receipt by the Administrative Agent of an executed counterpart of this Amendment. 

  
 6 

 4.5 Governing Law. This Amendment and the rights and obligations of the
parties hereto shall be governed by, and construed and interpreted in accordance with, the law of the State of New York. 
 4.6
Loan Document and Integration. This Amendment is a Loan Document, and together with the other Loan Documents, incorporates all negotiations of the parties hereto with respect to the subject matter hereof and is the final expression and
agreement of the parties hereto with respect to the subject matter hereof. 
 4.7 Headings. Section headings
contained in this Amendment are included herein for convenience of reference only and shall not constitute a part of this Amendment for any other purposes. 
 4.8 Waiver of Jury Trial. EACH OF THE PARTIES HERETO IRREVOCABLY WAIVES TRIAL BY JURY IN ANY ACTION OR PROCEEDING WITH RESPECT TO THIS AMENDMENT OR ANY OTHER LOAN DOCUMENT. 

[SIGNATURE PAGES FOLLOW] 

  
 7 

 IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be executed by
their respective officers and members thereunto duly authorized, as of the date indicated above. 
  

			
	ALLISON TRANSMISSION HOLDINGS, INC.
		
	By:	 	 /s/ David S. Graziosi

	Name:	 	David S. Graziosi
	Title:	 	Chief Financial Officer
	
	ALLISON TRANSMISSION, INC.
		
	By:	 	 /s/ David S. Graziosi

	Name:	 	David S. Graziosi
	Title:	 	Chief Financial Officer

 [SIGNATURE PAGE TO AMENDMENT NO. 4] 

 
			
	 CITICORP NORTH AMERICA, INC., as Administrative Agent and Collateral Agent

		
	By:	 	 /s/ Matthew Burke

	Name:	 	Matthew Burke
	Title:	 	Director

 [SIGNATURE PAGE TO AMENDMENT NO. 4] 

 Name of Lender: Merrill Lynch, Pierce, Fenner & Smith Incorporated 

 

			
	Executing as an Initial Term B-3 Lender:
		
	by	 	 /s/ Mark W. Kushemba

	Name:	 	Mark W. Kushemba
	Title:	 	Director
	
	For any Institution requiring a second signature line:
		
	by	 	  

	Name:	 	
	Title:	 	

  

					
	 Credit Agreement Reference
	  	Aggregate Principal Amount	 
	 Term B-3 Loans
	  	$	850,000,000.00	  

 [SIGNATURE PAGE TO AMENDMENT NO. 4] 

 Exhibit A 
 FORM OF CLOSING CERTIFICATE 
 CLOSING CERTIFICATE 

OF 

ALLISON TRANSMISSION HOLDINGS, INC. 
 Pursuant to Section 2.1(c) of Amendment No. 4, dated as of August 23, 2012 (the “Amendment”; unless otherwise defined herein, terms defined in the Amendment and used herein
shall have the meanings given to them in the Amendment), to that certain Credit Agreement, dated as of August 7, 2007 (as amended, restated, supplemented or otherwise modified from time to time, including but not limited to, the Amendment, the
“Credit Agreement”), among Allison Transmission Holdings, Inc. (“Holdings”), Allison Transmission, Inc. (the “Borrower”), the several banks and other financial institutions or entities from time to
time parties to the Credit Agreement as lenders (the “Lenders”), Citicorp North America, Inc., as Administrative Agent, and the other agents and arrangers parties thereto, the undersigned Assistant Secretary of Allison Transmission
Holdings, Inc. (the “Company”), hereby certifies on behalf of the Company as follows: 
  

	 	1.	Eric C. Scroggins is the duly elected and qualified Secretary of the Company and the signature set forth for such officer below is such officer’s true and genuine
signature. 

 The undersigned Secretary of the Company hereby certifies as follows: 

 

	 	1.	Attached hereto as Annex 1 is a true and complete copy of a Certificate of Good Standing or the equivalent from the Company’s jurisdiction of organization
dated as of a recent date prior to the date hereof. 

  

	 	2.	Attached hereto as Annex 2 is a true and complete copy of resolutions duly adopted by the Board of Directors of the Company on August 23, 2012. Such
resolutions have not in any way been amended, modified, revoked or rescinded, have been in full force and effect since their adoption to and including the date hereof and are now in full force and effect and are the only corporate proceedings of the
Company now in force relating to or affecting the matters referred to therein. 

  

	 	3.	Attached hereto as Annex 3 is a true and complete copy of the Bylaws of the Company as in effect on the date hereof. 

 

	 	4.	Attached hereto as Annex 4 is a true and complete certified copy of the Articles of Incorporation of the Company as in effect on the date hereof, and such
Articles of Incorporation have not been amended, repealed, modified or restated. 

  

	 	5.	The persons listed on Schedule I hereto are now duly elected and qualified officers of the Company holding the offices indicated next to their respective names on
Schedule I hereto, and the signatures appearing opposite their respective names on Schedule I hereto are the true and genuine signatures of such officers, and each of such officers is duly authorized to execute and deliver on behalf of the Company
each of the Loan Documents to which it is a party and any certificate or other document to be delivered by the Company pursuant to the Loan Documents to which it is a party. 

	 	6.	Latham & Watkins LLP may rely on this certificate in rendering its opinion. 

 IN WITNESS WHEREOF, the undersigned have hereunto set our names as of the date set forth
below. 
  

									
		 		 		 	ALLISON TRANSMISSION HOLDINGS, INC.
			
	 /s/ Eric C. Scroggins
	 		 	 /s/ David S. Graziosi

	Name:	 	Eric C. Scroggins	 		 	Name:	 	David S. Graziosi
	Title:	 	Vice President, General Counsel and Secretary	 		 	Title:	 	Executive Vice President, Chief Financial Officer, Treasurer and Assistant Secretary

 Date: August 23, 2012 

 Schedule I 
 to Closing Certificate 
  

					
	 NAME
	  	 OFFICE
	 	 SIGNATURE

			
	David S. Graziosi	  	Executive Vice President, Chief Financial Officer, Treasurer and Assistant Secretary	 	 /s/ David S. Graziosi

			
	Eric C. Scroggins	  	Vice President, General Counsel and Secretary	 	 /s/ Eric C. ScrogginsExecutive Employment Agreement

 Exhibit 10.01 
 EXECUTIVE EMPLOYMENT AGREEMENT 
 THIS EXECUTIVE EMPLOYMENT AGREEMENT (this
“Agreement”), dated as of August 21, 2012, (the “Effective Date”) is made and entered by and between Symantec Corporation, a Delaware corporation (the “Company”), and Steve Bennett (the “Executive”).

 WITNESSETH: 
 WHEREAS, the Executive is currently employed as the Company’s President and Chief Executive Officer and is expected to make major contributions to the short- and long-term profitability, growth and
financial strength of the Company; 
 WHEREAS, the Company has determined that appropriate arrangements should be taken to
encourage the continued attention and dedication of the Executive to his assigned duties without distraction; and 
 WHEREAS, in
consideration of the Executive’s employment with the Company, the Company desires to provide the Executive with certain compensation and benefits as set forth in this Agreement in order to ameliorate the financial and career impact on the
Executive in the event the Executive’s employment with the Company is terminated for a reason related to, or unrelated to, a Change in Control (as defined below) of the Company. 

NOW, THEREFORE, in consideration of the foregoing and the mutual covenants and agreements hereinafter set forth and intending to be
legally bound hereby, the Company and the Executive agree as follows: 
 1. Certain Defined Terms. In addition to terms
defined elsewhere herein, the following terms have the following meanings when used in this Agreement with initial capital letters: 
 (a) “Annual Base Salary” means the Executive’s annual base salary rate, exclusive of bonuses, commissions and other incentive pay, as in effect immediately preceding Executive’s
Termination Date. As of the Effective Date, Executive’s annual base salary is $1,000,000. 
 (b) “Board” means
the Board of Directors of the Company. 
 (c) “Cause” means: 

(i) an intentional tort (excluding any tort relating to a motor vehicle) which causes substantial loss, damage or injury
to the property or reputation of the Company or its subsidiaries; 

 (ii) any serious crime or intentional, material act of fraud or dishonesty
against the Company; 
 (iii) the commission of a felony that results in other than immaterial harm to the
Company’s business or to the reputation of the Company or Executive; 
 (iv) habitual neglect of
Executive’s reasonable duties (for a reason other than illness or incapacity) which is not cured within ten (10) days after written notice thereof by the Board to the Executive; 

(v) the disregard of written, material policies of the Company or its subsidiaries which causes other than immaterial
loss, damage or injury to the property or reputation of the Company or its subsidiaries which is not cured within ten (10) days after written notice thereof by the Board to the Executive; or 

(vi) any material breach of the Executive’s ongoing obligation not to disclose confidential information and not to
assign intellectual property developed during employment which, if capable of being cured, is not cured within ten (10) days after written notice thereof by the Board to the Executive. 

(d) “Change in Control” means: 
 (i) any person or entity becoming the beneficial owner, directly or indirectly, of securities of the Company representing forty (40%) percent of the total voting power of all its then outstanding
voting securities; 
 (ii) a merger or consolidation of the Company in which its voting securities immediately
prior to the merger or consolidation do not represent, or are not converted into securities that represent, a majority of the voting power of all voting securities of the surviving entity immediately after the merger or consolidation; 

(iii) a sale of substantially all of the assets of the Company or a liquidation or dissolution of the Company; or

 (iv) individuals who, as of the date of the signing of this Agreement, constitute the Board of Directors (the
“Incumbent Board”) cease for any reason to constitute at least a majority of such Board; provided that any individual who becomes a director of the Company subsequent to the date of the signing of this Agreement, whose election, or
nomination for election by the Company stockholders, was approved by the vote of at least a majority of the directors then in office shall be deemed a member of the Incumbent Board. 

(e) “COBRA” means the Consolidated Omnibus Budget Reconciliation Act of 1986, as amended. 

  
 2 

 (f) “Disability” means (i) the Executive has been incapacitated by
bodily injury, illness or disease so as to be prevented thereby from engaging in the performance of the Executive’s duties (provided, however, that the Company acknowledges its obligations to provide reasonable accommodation to the extent
required by applicable law); (ii) such total incapacity shall have continued for a period of six (6) consecutive months; and (iii) such incapacity will, in the opinion of a qualified physician, be permanent and continuous during the
remainder of the Executive’s life. 
 (g) “Good Reason Termination” means: 

(i) a material diminution in the Executive’s base compensation or target bonus below the amount as of the date of
this Agreement or as increased during the course of his employment with the Company, excluding one or more reductions (totaling no more than 20% in the aggregate) generally applicable to all senior executives provided, however, that such exclusion
shall not apply if the material diminution in the Executive’s base compensation occurs within (A) 60 days prior to the consummation of a Change in Control where such Change in Control was under consideration at the time of Executive’s
Termination Date or (B) twelve (12) months after the date upon which such a Change in Control occurs; 

(ii) a material diminution in the Executive’s authority, duties or responsibilities; 

(iii) a requirement that that the Executive report to a corporate officer or employee of the Company instead of reporting
directly to the Board (or if the Company has a parent corporation, a requirement that the Executive report to any individual or entity other than the board of the ultimate parent corporation of the Company); 

(iv) a material diminution in the budget over which the Executive retains authority; 

(v) a material change in the geographic location at which the Executive must perform services; or 

(vi) any action or inaction that constitutes a material breach by the Company of this Agreement; 

provided, however, that for the Executive to be able to terminate his employment with the Company on account of Good
Reason he must provide notice of the occurrence of the event constituting Good Reason and his desire to terminate his employment with the Company on account of such within ninety (90) days following the initial existence of the condition
constituting Good Reason, and the Company must have a period of thirty (30) days following receipt of such notice to cure the condition. If the Company does not cure the event constituting Good Reason within such thirty (30) day period,
the Executive’s Termination Date shall be the day immediately following the end of such thirty (30) day period, unless the Company provides for an earlier Termination Date. 

  
 3 

 (h) “Target Bonus” means the target payout (i.e., at 100% achievement of each of
the applicable metric(s) in effect from time to time) under the Company’s Executive Annual Incentive Plan in effect for the Executive as of the Termination Date. As of the Effective Date, Executive’s target bonus percentage under the
Executive Annual Incentive Plan is 150% of annual base salary. 
 (i) “Termination Date” means the last day of
Executive’s employment with the Company. 
 (j) “Termination of Employment” means the termination of
Executive’s active employment relationship with the Company. 
 2. Termination Unrelated to a Change in Control.

 (a) Involuntary Termination Unrelated to a Change in Control. In the event of: (i) an involuntary termination of
Executive’s employment by the Company for any reason other than Cause, death or Disability, or (ii) Executive’s resignation for Good Reason, and if Section 3 does not apply, Executive shall be entitled to the benefits provided in
subsection (b) of this Section 2. 
 (b) Compensation Upon Termination Unrelated to a Change in Control.
Subject to the provisions of Section 5 hereof, in the event a termination described in subsection (a) of this Section 2 occurs, the Company shall provide Executive with the following, provided that Executive executes and does not
revoke the Release (as defined in Section 5): 
 (i) 1.5 times the sum of Annual Base Salary and Target
Bonus, paid in a single lump sum cash payment on the sixtieth (60th) day following Executive’s Termination Date. (For purposes of this subsection (i), Annual Base Salary will mean the largest among the following: Executive’s
annual base salary immediately prior to (A) Executive’s Termination Date, or (B) any reduction of Executive’s base salary described in the first clause of subsection (i) in the definition of Good Reason. For purposes of
this subsection (i), Target Bonus will mean the largest among the following: Executive’s target bonus immediately prior to (A) Executive’s Termination Date, or (B) any reduction of Executive’s target bonus described in the
first clause of subsection (i) in the definition of Good Reason.) 
 (ii) For a period of up to
eighteen (18) months following Executive’s Termination Date, Executive and where applicable, Executive’s spouse and eligible dependents, will continue to be eligible to receive medical coverage under the Company’s medical plans
in accordance with the terms of the applicable plan documents; provided, that in order to receive such continued coverage at such rates, Executive will be required to pay the applicable premiums to the plan provider, and the Company will reimburse
the Executive, within 60 

  
 4 

 
days following the date such monthly premium payment is due, an amount equal to the monthly COBRA premium payment, less applicable tax withholdings. Notwithstanding the foregoing, if Executive
obtains full-time employment during this eighteen (18) month period that entitles him and his spouse and eligible dependents to comprehensive medical coverage, Executive must notify the Company and no further reimbursements will be paid by the
Company to the Executive pursuant to this subsection. In addition, if Executive does not pay the applicable monthly COBRA premium for a particular month at any time during the eighteen (18) month period and coverage is lost as a result, no
further reimbursements will be paid by the Company to the Executive pursuant to this subsection. Notwithstanding the above, if the Company determines in its sole discretion that it cannot provide the foregoing COBRA benefits without potentially
violating applicable law (including, without limitation, Section 2716 of the Public Health Service Act), the Company shall in lieu thereof provide to Executive a taxable lump-sum payment in an amount equal to the monthly (or then remaining)
COBRA premium that Executive would be required to pay to continue his group health coverage in effect on the Termination Date (which amount shall be based on the premium for the first month of COBRA coverage).  

(iii) With respect to any outstanding Company stock options held by the Executive as of his Termination Date that are not
vested and exercisable as of such date, the Company shall accelerate the vesting of that portion of the Executive’s stock options, if any, which would have vested and become exercisable within the eighteen (18) month period after the
Executive’s Termination Date, such options (as well as any outstanding stock options that previously became vested and exercisable) to remain exercisable, notwithstanding anything in any other agreement governing such options, until the earlier
of (A) a period of one year after the Executive’s Termination Date, or (B) the original term of the option. Except as provided in this Section 2(b)(iii) and in Section 3(b)(iii) below, any portion of Executive’s
outstanding stock options that are not vested and exercisable as of Executive’s Termination Date shall terminate. 
 (iv) With respect to any restricted stock units representing shares of Company common stock (“Restricted Stock Units”) held by the Executive that are unvested at the time of his Termination
Date, the number of unvested Restricted Stock Units that would have vested within the eighteen (18) month period after the Executive’s Termination Date shall vest, and settle not later than sixty (60) days following the Termination
Date. Except as provided in this Section 2(b)(iv) and in Section 3(b)(iv) below, any Restricted Stock Units that are not vested as of Executive’s Termination Date shall terminate. 

(v) Any amounts that have been accrued for the account of the Executive under the Company’s Long Term Incentive Plan
(“LTIP”) that have not been released to the Executive as of the Termination Date shall be released to the executive, as applicable, in accordance with the terms of any applicable LTIP then in effect under the circumstances described
therein as an involuntary termination other than for cause. 

  
 5 

 (vi) With respect to any Performance-based Restricted Stock Units
(“PRUs”) held by the Executive that have not been released to the Executive pursuant to the terms of the applicable Performance Based Restricted Share Unit Award Agreement (the “PRU Agreement”) as of the Termination Date shall be
treated in accordance with the terms of the applicable PRU Agreement as an involuntary termination other than for cause. 
 (vii) With respect to any Performance Contingent Stock Units (“PCSUs”) held by the Executive that have not been released to the Executive pursuant to the terms of the applicable Performance
Contingent Stock Unit Agreement (the “PCSU Agreement”) as of the Termination Date shall be treated in accordance with the terms of the applicable PCSU Agreement as an involuntary termination other than for cause. 

(viii) Executive shall receive any amounts earned, accrued or owing but not yet paid to Executive as of his Termination
Date, payable in a lump sum, and any benefits accrued or earned in accordance with the terms of any applicable benefit plans and programs of the Company. 
 3. Termination Related to a Change in Control. 
 (a) Involuntary
Termination Relating to a Change in Control. In the event Executive’s employment is terminated on account of (i) an involuntary termination by the Company for any reason other than Cause, death or Disability, or (ii) the Executive
voluntarily terminates employment with the Company on account of a resignation for Good Reason, in either case that occurs (x) at the same time as, or within the twelve (12) month period following, the consummation of a Change in Control
or (y) within the sixty (60) day period prior to the date of a Change in Control where the Change in Control was under consideration at the time of Executive’s Termination Date, then Executive shall be entitled to the benefits
provided in subsection (b) of this Section 3. 
 (b) Compensation Upon Involuntary Termination Relating to a Change
in Control. Subject to the provisions of Section 5 hereof, in the event a termination described in subsection (a) of this Section 3 occurs, the Company shall provide that the following be paid to the Executive after his
Termination Date, provided that Executive executes and does not revoke the Release: 
 (i) 2.0 times the sum of
Annual Base Salary and Target Bonus, paid in a single lump sum cash payment on the sixtieth (60th) day following Executive’s Termination Date. Notwithstanding the foregoing, to the extent Executive is entitled to receive the severance
benefit payable pursuant to Section 2(b)(i) as a result of a qualifying termination prior to a Change in Control and then becomes entitled to receive the severance benefit payable pursuant to this Section 3 as a result of the Change in
Control that was considered at the time of Executive’s Termination Date becoming consummated within sixty (60) days following Executive’s Termination Date, Executive shall not receive the

  
 6 

 
severance benefit payable pursuant to Section 2(b)(i) of this Agreement, but instead shall receive the severance benefit payable pursuant to this Section 3(b)(i) on the sixtieth
(60th) day following Executive’s Termination Date. (For purposes of this subsection (i), Annual Base Salary will mean the largest among the following: Executive’s annual base salary immediately prior to (A) Executive’s
Termination Date, (B) any reduction of Executive’s base salary described in the first clause of subsection (i) in the definition of Good Reason, or (C) immediately prior to the Change in Control. For purposes of this
subsection (i), Target Bonus will mean the largest among the following: Executive’s target bonus (A) immediately prior to Executive’s Termination Date, (B) immediately prior to any reduction of Executive’s target bonus
described in the first clause of subsection (i) in the definition of Good Reason, (C) immediately prior to the Change in Control, or (d) for the fiscal year preceding the year in which the Change in Control.) 

(ii) For a period of up to twenty-four (24) months following Executive’s Termination Date, Executive and where
applicable, Executive’s spouse and eligible dependents, will continue to be eligible to receive medical coverage under the Company’s medical plans in accordance with the terms of the applicable plan documents; provided, that in order to
receive such continued coverage at such rates, Executive will be required to pay the applicable premiums to the plan provider, and the Company will reimburse the Executive, within sixty (60) days following the date such monthly premium payment
is due, an amount equal to the monthly COBRA (or, as applicable, other) premium payment, less applicable tax withholdings. Notwithstanding the foregoing, if Executive obtains full-time employment during this twenty-four (24) month period that
entitles him and his spouse and eligible dependents to comprehensive medical coverage, Executive must notify the Company and no further reimbursements will be paid by the Company to the Executive pursuant to this subsection. In addition, if
Executive does not pay the applicable monthly COBRA (or other) premium for a particular month at any time during the twenty-four (24) month period and coverage is lost as a result, no further reimbursements will be paid by the Company to the
Executive pursuant to this subsection. Notwithstanding the foregoing, to the extent Executive is entitled to receive the severance benefit provided pursuant to Section 2(b)(ii) of the Agreement as a result of a qualifying termination prior to a
Change in Control, if Executive becomes entitled to receive the severance benefits payable pursuant to this Section 3 as a result of the Change in Control that was considered at the time of Executive’s Termination Date becoming consummated
within sixty (60) days following Executive’s Termination Date, Executive shall be entitled to receive the severance benefit provided pursuant to this clause (ii) and not the benefit provided pursuant to Section 2(b)(ii).
Notwithstanding the above, if the Company determines in its sole discretion that it cannot provide the foregoing COBRA benefits without potentially violating applicable law (including, without limitation, Section 2716 of the Public Health
Service Act), the Company shall in lieu thereof provide to Executive a taxable lump-sum payment in an amount equal to the monthly (or then remaining) COBRA premium that Executive would be required to pay to continue his group health coverage in
effect on the Termination Date (which amount shall be based on the premium for the first month of COBRA coverage). 

  
 7 

 (iii) With respect to any outstanding Company stock options held by the
Executive as of his Termination Date, the Company shall fully accelerate the vesting and exercisability of such stock options, so that all such stock options shall be fully vested and exercisable as of Executive’s Termination Date, such options
(as well as any outstanding stock options that previously became vested and exercisable) to remain exercisable, notwithstanding anything in any other agreement governing such options, until the earlier of (A) a period of one year after the
Executive’s Termination Date, or (B) the original term of the option. Notwithstanding the foregoing, to the extent Executive is entitled to receive the vesting and exercisability acceleration provided pursuant to Section 2(b)(iii) of
the Agreement as a result of a qualifying termination prior to a Change in Control, if Executive becomes entitled to receive the severance benefits payable pursuant to this Section 3 as a result of the Change in Control that was considered at
the time of Executive’s Termination Date becoming consummated within sixty (60) days following Executive’s Termination Date, any outstanding stock options that did not become vested and exercisable pursuant to Section 2(b)(iii)
shall become vested and exercisable as of the date of the Change in Control; provided, however, if a Change in Control does not occur within sixty (60) days following Executive’s Termination Date, any stock options held by Executive that
are not vested and exercisable shall terminate as of the sixtieth (60th) day following Executive’s Termination Date or the end of the term, if earlier. 

(iv) With respect to any Restricted Stock Units held by the Executive that are unvested at the time of his Termination
Date, all such unvested Restricted Stock Units shall vest and settle not later than sixty (60) days following the Termination Date. Notwithstanding the foregoing, to the extent Executive is entitled to receive the vesting acceleration provided
pursuant to Section 2(b)(iv) of the Agreement as a result of a qualifying termination prior to a Change in Control, if Executive becomes entitled to receive the severance benefits payable pursuant to this Section 3 as a result of the
Change in Control that was considered at the time of Executive’s Termination Date becoming consummated within sixty (60) days following Executive’s Termination Date, any outstanding Restricted Stock Units that did not become vested
pursuant to Section 2(b)(iv) shall become vested as of the date of the Change in Control; provided, however, if a Change in Control does not occur within sixty (60) days following Executive’s Termination Date, any Restricted Stock
Units held by Executive that are not vested shall terminate as of the sixtieth (60th) day following Executive’s Termination Date. 
 (v) Any amounts that have been accrued for the account of the Executive under the LTIP that have not been released to the Executive as of the Termination Date shall be released to the executive, as
applicable, in accordance with the terms of any applicable LTIP then in effect under the circumstances described therein as a “Change of Control of the Company” (as 

  
 8 

 
defined therein).With respect to any PRUs held by the Executive that have not been released to the Executive pursuant to the terms of the applicable PRU Agreement as of the Termination Date shall
be treated in accordance with the terms of the applicable PRU Agreement as a “Change of Control of the Company” (as defined therein). 
 (vi) With respect to any PCSUs held by the Executive that have not been released to the Executive pursuant to the terms of the applicable PCSU Agreement as of the Termination Date shall be treated in
accordance with the terms of the applicable PCSU Agreement as a “Change of Control of the Company” (as defined therein). 
 (vii) Executive shall receive any amounts earned, accrued or owing but not yet paid to Executive as of his Termination Date, payable in a lump sum, and any benefits accrued or earned in accordance with
the terms of any applicable benefit plans and programs of the Company. 
 (c) Consequence of a Change in Control. Notwithstanding the
terms of the Symantec 2004 Executive Incentive Plan (the “2004 Plan”), if, as of the date of a Change in Control, Executive holds stock options issued under the 2004 Plan that are not vested and exercisable, such stock options shall become
fully vested and exercisable as of the date of the Change in Control if the acquirer does not agree to assume or substitute for equivalent stock options such outstanding stock options. 

4. Termination of Employment on Account of Disability, Death, Cause or Voluntarily Without Good Reason. 

(a) Termination on Account of Disability. Notwithstanding anything in this Agreement to the contrary, if Executive’s
employment terminates on account of Disability, Executive shall be entitled to receive disability benefits under any disability program maintained by the Company that covers Executive, and Executive shall not receive benefits pursuant to Sections 2
and 3 hereof, except that, subject to the provisions of Section 5 hereof, the Executive shall be entitled to the following benefits provided that Executive executes and does not revoke the Release: 

(i) For a period of up to eighteen (18) months following Executive’s Termination Date, Executive and where
applicable, Executive’s spouse and eligible dependents, will continue to be eligible to receive medical coverage under the Company’s medical plans in accordance with the terms of the applicable plan documents; provided, that in order to
receive such continued coverage at such rates, Executive will be required to pay the applicable premiums to the plan provider, and the Company will reimburse the Executive, within 60 days following the date such monthly premium payment is due, an
amount equal to the monthly COBRA premium payment, less applicable tax withholdings. Notwithstanding the foregoing, if Executive obtains full-time employment during this eighteen (18) month period that entitles him and his spouse and eligible
dependents to comprehensive medical coverage, Executive 

  
 9 

 
must notify the Company and no further reimbursements will be paid by the Company to the Executive pursuant to this subsection. In addition, if Executive does not pay the applicable monthly
COBRA premium for a particular month at any time during the eighteen (18) month period and coverage is lost as a result, no further reimbursements will be paid by the Company to the Executive pursuant to this subsection. Notwithstanding the
above, if the Company determines in its sole discretion that it cannot provide the foregoing COBRA benefits without potentially violating applicable law (including, without limitation, Section 2716 of the Public Health Service Act), the Company
shall in lieu thereof provide to Executive a taxable lump-sum payment in an amount equal to the monthly (or then remaining) COBRA premium that Executive would be required to pay to continue his group health coverage in effect on the Termination Date
(which amount shall be based on the premium for the first month of COBRA coverage). 
 (ii) With respect to any
outstanding Company stock options held by the Executive as of his Termination Date that are not vested and exercisable as of such date, the Company shall fully accelerate the vesting and exercisability of such stock options, so that all such stock
options shall be fully vested and exercisable as of the Executive’s Termination Date, such options (as well as any outstanding stock options that previously became vested and exercisable) to remain exercisable, notwithstanding anything in any
other agreement governing such options, until the earlier of (A) a period of one year after the Executive’s Termination Date, or (B) the original term of the option. 

(iii) With respect to any Restricted Stock Units held by the Executive that are unvested at the time of his Termination
Date, all such unvested Restricted Stock Units shall vest and settle not later than sixty (60) days following his Termination Date. 
 (iv) Any amounts that have been accrued for the account of the Executive under the LTIP that have not been released to the Executive as of the Termination Date shall be released to the executive, as
applicable, in accordance with the terms of any applicable LTIP then in effect under the circumstances described therein as a termination by reason of total and permanent disability. 

(v) With respect to any PRUs held by the Executive that have not been released to the Executive pursuant to the terms of
the applicable PRU Agreement as of the Termination Date shall be treated in accordance with the terms of the applicable PRU Agreement as a termination of employment by reason of total and permanent disability. 

(vi) With respect to any PCSUs held by the Executive that have not been released to the Executive pursuant to the terms of
the applicable PCSU Agreement as of the Termination Date shall be treated in accordance with the terms of the applicable PCSU Agreement as a termination of employment by reason of total and permanent disability. 

  
 10 

 (b) Termination on Account of Death. Notwithstanding anything in this Agreement to the contrary, if
Executive’s employment terminates on account of death, Executive shall be entitled to receive death benefits under any death benefit program maintained by the Company that covers Executive, and Executive not receive benefits pursuant to
Sections 2 and 3 hereof, except that, subject to the provisions of Section 5 hereof, the Executive shall be entitled to the following benefits provided that Executive’s estate executes and does not revoke the Release: 

(i) With respect to any outstanding Company stock options held by the Executive as of his death that are not vested and
exercisable as of such date, the Company shall fully accelerate the vesting and exercisability of such stock options, so that all such stock options shall be fully vested and exercisable as of the Executive’s death, such options (as well as any
outstanding stock options that previously became vested and exercisable) to remain exercisable, notwithstanding anything in any other agreement governing such options, until the earlier of (A) a period of one year after the Executive’s
death or (B) the original term of the option. 
 (ii) With respect to any Restricted Stock Units held by the
Executive that are unvested at the time of his death, all such unvested Restricted Stock Units shall vest and settle not later than sixty (60) days following his death. 

(iii) Any amounts that have been accrued for the account of the Executive under the LTIP that have not been released to
the Executive as of his death shall be released to the executive, as applicable, in accordance with the terms of any applicable LTIP then in effect under the circumstances described therein as a termination by reason of death. 

(iv) With respect to any PRUs held by the Executive that have not been released to the Executive pursuant to the terms of
the applicable PRU Agreement as of his death shall be treated in accordance with the terms of the applicable PRU Agreement as a termination of employment by reason of death. 

(v) With respect to any PCSUs held by the Executive that have not been released to the Executive pursuant to the terms of
the applicable PCSU Agreement as of his death shall be treated in accordance with the terms of the applicable PCSU Agreement as a termination of employment by reason of death. 
 (c) Termination on Account of Cause. Notwithstanding anything in this Agreement to the contrary, if Executive’s employment terminates by the Company on account of Cause, Executive shall not
receive benefits pursuant to Sections 2 and 3 hereof. 
 (d) Termination on Account of Voluntary Resignation Without Good
Reason. Notwithstanding anything in this Agreement to the contrary, if Executive’s 

  
 11 

 
employment terminates on account of a resignation by Executive for no reason or any reason other than on account of Good Reason, Executive shall not receive benefits pursuant to Sections 2 and 3
hereof. 
 5. Release. Notwithstanding the foregoing, no payments or other benefits under this Agreement shall be made
unless Executive executes, and does not revoke, the Company’s standard written release, substantially in the form as attached hereto as Annex A, (the “Release”), of any and all claims against the Company and all related parties
with respect to all matters arising out of Executive’s employment by the Company (other than entitlements under the terms of this Agreement or under any other plans or programs of the Company in which Executive participated and under which
Executive has accrued or become entitled to a benefit) or a termination thereof, with such release being effective not later than sixty (60) days following Executive’s Termination Date. 

6. No Mitigation Obligation. Executive shall not be required to mitigate the amount of any payment or benefit provided for in this
Agreement by seeking other employment or otherwise, nor shall the amount of any payment or benefit provided for herein be reduced by any compensation earned by other employment or otherwise. 

7. Employment Rights. Nothing expressed or implied in this Agreement will create any right or duty on the part of the Company or
the Executive to have the Executive remain in the employment of the Company or any subsidiary prior to or following any Change in Control. 
 8. PRU Agreement. Notwithstanding the provisions of the PRU Agreement, Executive’s Conditional PRU Award for the Performance Period beginning in fiscal year 2012 and ending at the end of
fiscal year 2014 shall be not less than 80,000 PRUs (capitalized terms used in this Section 8 but not defined herein shall have the meanings ascribed to them in the PRU Agreement). 

9. Tax Matters 
 (a) Withholding of Taxes. The Company may withhold from any amounts payable under this Agreement all federal, state, city or other taxes as the Company is required to withhold pursuant to any
applicable law, regulation or ruling. 
 (b) Parachute Excise Tax. In the event that any amounts payable under this Agreement or
otherwise to Executive would (i) constitute “parachute payments” within the meaning of section 280G of the Internal Revenue Code of 1986, as amended (the “Code”), or any comparable successor provisions and (ii) but for
this Subsection (b) would be subject to the excise tax imposed by section 4999 of the Code or any comparable successor provisions (the “Excise Tax”), then such amounts payable to Executive hereunder shall be either: 

(i) Provided to Executive in full; or 
 (ii) Provided to Executive to the maximum extent that would result in no portion of such benefits being subject to the Excise Tax; 

  
 12 

 whichever of the foregoing amounts, when taking into account applicable federal, state, local and foreign
income and employment taxes, the Excise Tax and any other applicable taxes, results in the receipt by Executive, on an after-tax basis, of the greatest amount of benefits, notwithstanding that all or some portion of such benefits may be taxable
under the Excise Tax. Unless the Company and Executive otherwise agree in writing, any determination required under this Subsection (b) shall be made in writing in good faith by a nationally recognized accounting firm (the
“Accountants”). In the event of a reduction in benefits hereunder, the reduction of the total payments shall apply as follows, unless otherwise agreed in writing and such agreement is in compliance with section 409A of the Code:
(i) any cash severance payments subject to Section 409A of the Code due under this Agreement shall be reduced, with the last such payment due first forfeited and reduced, and sequentially thereafter working from the next last payment,
(ii) any cash severance payments not subject to Section 409A of the Code due under this Agreement shall be reduced, with the last such payment due first forfeited and reduced, and sequentially thereafter working from the next last payment;
(iii) any acceleration of vesting of any equity subject to Section 409A of the Code shall remain as originally scheduled to vest, with the tranche that would vest last (without any such acceleration) first remaining as originally scheduled
to vest; and (iv) any acceleration of vesting of any equity not subject to Section 409A of the Code shall remain as originally scheduled to vest, with the tranche that would vest last (without any such acceleration) first remaining as
originally scheduled to vest. For purposes of making the calculations required by this Subsection (b), the Accountants may make reasonable assumptions and approximations concerning applicable taxes and may rely on reasonable, good-faith
interpretations concerning the application of the Code and other applicable legal authority. The Company and Executive shall furnish to the Accountants such information and documents as the Accountants may reasonably request in order to make a
determination under this Subsection (b). The Company shall bear all costs that the Accountants may reasonably incur in connection with any calculations contemplated by this Subsection (b). 
 If, notwithstanding any reduction described in this Subsection (b), the Internal Revenue Service (“IRS”) determines that Executive is liable for the Excise Tax as a result of the receipt of
amounts payable under this Agreement or otherwise as described above, then Executive shall be obligated to pay back to the Company, within thirty (30) days after a final IRS determination or, in the event that Executive challenges the final IRS
determination, a final judicial determination, a portion of such amounts equal to the Repayment Amount. The “Repayment Amount” with respect to the payment of benefits shall be the smallest such amount, if any, that is required to be paid
to the Company so that Executive’s net after-tax proceeds with respect to any payment of benefits (after taking into account the payment of the Excise Tax and all other applicable taxes imposed on such payment) are maximized. The Repayment
Amount with respect to the payment of benefits shall be zero if a Repayment Amount of more than zero would not result in Executive’s net after-tax proceeds with respect to the payment of such benefits being maximized. If the Excise Tax is not
eliminated pursuant to this paragraph, Executive shall pay the Excise Tax. 

  
 13 

 Notwithstanding any other provision of this Subsection (b), if (i) there is a reduction in the payment
of benefits as described in this Subsection (b), (ii) the IRS later determines that Executive is liable for the Excise Tax, the payment of which would result in the maximization of Executive’s net after-tax proceeds (calculated as if
Executive’s benefits had not previously been reduced), and (iii) Executive pays the Excise Tax, then the Company shall pay to Executive those benefits which were reduced pursuant to this Subsection (b) as soon as administratively
possible after Executive pays the Excise Tax, so that Executive’s net after-tax proceeds with respect to the payment of benefits are maximized. 
 10. Term of Agreement. This Agreement shall continue in full force and effect until the third anniversary of the Effective Date (the “Initial Term”), and shall automatically renew for
additional one (1) year renewal periods (a “Renewal Term”) if Executive is employed by the Company on the last day of the Initial Term and on each Renewal Term; provided, however, that within the sixty (60) to ninety
(90) day period prior to the expiration of the Initial Term or any Renewal Term, at its discretion, the Board may propose for consideration by Executive, such amendments to the Agreement as it deems appropriate. If Executive’s employment
with the Company terminates during the Initial Term or a Renewal Term, this Agreement shall remain in effect until all of the obligations of the parties hereunder are satisfied or have expired. 

11. Successors and Binding Agreement. 
 (a) The Company will require any successor (whether direct or indirect, by purchase, merger, consolidation, reorganization or otherwise) to all or substantially all of the business or assets of the
Company, by agreement in form and substance reasonably satisfactory to the Executive, expressly to assume and agree to perform this Agreement in the same manner and to the same extent the Company would be required to perform if no such succession
had taken place. This Agreement will be binding upon and inure to the benefit of the Company and any successor to the Company, including without limitation any persons acquiring directly or indirectly all or substantially all of the business or
assets of the Company whether by purchase, merger, consolidation, reorganization or otherwise (and such successor will thereafter be deemed the “Company” for the purposes of this Agreement), but will not otherwise be assignable,
transferable or delegable by the Company. 
 (b) This Agreement will inure to the benefit of and be enforceable by the
Executive’s personal or legal representatives, executors, administrators, successors, heirs, distributees and legatees. This Agreement will supersede the provisions of any employment, severance or other agreement between the Executive and the
Company that relate to any matter that is also the subject of this Agreement, and such provisions in such other agreements will be null and void. 

  
 14 

 (c) This Agreement is personal in nature and neither of the parties hereto will, without the
consent of the other, assign, transfer or delegate this Agreement or any rights or obligations hereunder except as expressly provided in Sections 10(a) and 10(b). Without limiting the generality or effect of the foregoing, the Executive’s right
to receive payments hereunder will not be assignable, transferable or delegable, whether by pledge, creation of a security interest, or otherwise, other than by a transfer by the Executive’s will or by the laws of descent and distribution and,
in the event of any attempted assignment or transfer contrary to this Section 10(c), the Company will have no liability to pay any amount so attempted to be assigned, transferred or delegated. 

12. Notices. For all purposes of this Agreement, all communications, including without limitation notices, consents, requests or
approvals, required or permitted to be given hereunder will be in writing and will be deemed to have been duly given when hand delivered or dispatched by electronic facsimile transmission (with receipt thereof orally confirmed), or five
(5) business days after having been mailed by United States registered or certified mail, return receipt requested, postage prepaid, or three business days after having been sent by a nationally recognized overnight courier service such as
FedEx or UPS, addressed to the Company (to the attention of the Secretary of the Company) at its principal executive office and to the Executive at his principal residence, or to such other address as any party may have furnished to the other in
writing and in accordance herewith, except that notices of changes of address will be effective only upon receipt. 
 13.
Section 409A of the Code. 
 (a) Interpretation. Notwithstanding the other provisions hereof, this Agreement
is intended to comply with the requirements of section 409A of the Code, to the extent applicable, and this Agreement shall be interpreted to avoid any penalty sanctions under section 409A of the Code. Accordingly, all provisions herein, or
incorporated by reference, shall be construed and interpreted to comply with section 409A of the Code and, if necessary, any such provision shall be deemed amended to comply with section 409A of the Code and regulations thereunder. If any payment or
benefit cannot be provided or made at the time specified herein without incurring sanctions under section 409A of the Code, then such benefit or payment shall be provided in full at the earliest time thereafter when such sanctions will not be
imposed. Any amount payable under this Agreement that constitutes deferred compensation subject to section 409A of the Code shall be paid at the time provided under this Agreement or such other time as permitted under section 409A of the Code. No
interest will be payable with respect to any amount paid within a time period permitted by, or delayed because of, section 409A of the Code. All payments to be made upon a termination of employment under this Agreement that are deferred compensation
may only be made upon a “separation from service” under section 409A of the Code. For purposes of section 409A of the Code, each payment made under this Agreement shall be treated as a separate payment. In no event may Executive, directly
or indirectly, designate the calendar year of payment. 

  
 15 

 (b) Payment Delay. To the maximum extent permitted under section 409A of the Code,
the severance benefits payable under this Agreement are intended to comply with the “short-term deferral exception” under Treas. Reg. §1.409A-1(b)(4), and any remaining amount is intended to comply with the “separation pay
exception” under Treas. Reg. §1.409A-1(b)(9)(iii); provided, however, any amount payable to Executive during the six (6) month period following Executive’s Termination Date that does not qualify within either of the foregoing
exceptions and constitutes deferred compensation subject to the requirements of section 409A of the Code, then such amount shall hereinafter be referred to as the “Excess Amount.” If at the time of Executive’s separation from service,
the Company’s (or any entity required to be aggregated with the Company under section 409A of the Code) stock is publicly-traded on an established securities market or otherwise and Executive is a “specified employee” (as defined in
section 409A of the Code and determined in the sole discretion of the Company (or any successor thereto) in accordance with the Company’s (or any successor thereto) “specified employee” determination policy), then the Company shall
postpone the commencement of the payment of the portion of the Excess Amount that is payable within the six (6) month period following Executive’s Termination Date with the Company (or any successor thereto) for six (6) months
following Executive’s Termination Date with the Company (or any successor thereto). The delayed Excess Amount shall be paid in a lump sum to Executive within ten (10) days following the date that is six (6) months following
Executive’s Termination Date with the Company (or any successor thereto). If Executive dies during such six (6) month period and prior to the payment of the portion of the Excess Amount that is required to be delayed on account of section
409A of the Code, such Excess Amount shall be paid to the personal representative of Executive’s estate within sixty (60) days after Executive’s death. 
 (c) Reimbursements. All reimbursements provided under this Agreement shall be made or provided in accordance with the requirements of section 409A of the Code, including, where applicable, the
requirement that (i) any reimbursement is for expenses incurred during Executive’s lifetime (or during a shorter period of time specified in this Agreement), (ii) the amount of expenses eligible for reimbursement during a calendar
year may not affect the expenses eligible for reimbursement in any other calendar year, (iii) the reimbursement of an eligible expense will be made on or before the last day of the taxable year following the year in which the expense is
incurred, and (iv) the right to reimbursement is not subject to liquidation or exchange for another benefit. Any tax gross up payments to be made hereunder shall be made not later than the end of Executive’s taxable year next following
Executive’s taxable year in which the related taxes are remitted to the taxing authority. 
 14. Governing Law. The
validity, interpretation, construction and performance of this Agreement will be governed by and construed in accordance with the substantive laws of the State of California, without giving effect to the principles of conflict of laws of such State.

 15. Validity. If any provision of this Agreement or the application of any provision hereof to any person or
circumstances is held invalid, unenforceable or 

  
 16 

 
otherwise illegal, the remainder of this Agreement and the application of such provision to any other person or circumstances will not be affected, and the provision so held to be invalid,
unenforceable or otherwise illegal will be reformed to the extent (and only to the extent) necessary to make it enforceable, valid or legal. 
 16. Miscellaneous. No provision of this Agreement may be modified, waived or discharged unless such waiver, modification or discharge is agreed to in writing signed by the Executive and the
Company. No waiver by either party hereto at any time of any breach by the other party hereto or compliance with any condition or provision of this Agreement to be performed by such other party will be deemed a waiver of similar or dissimilar
provisions or conditions at the same or at any prior or subsequent time. No agreements or representations, oral or otherwise, expressed or implied with respect to the subject matter hereof have been made by either party that are not set forth
expressly in this Agreement. References to Sections are to references to Sections of this Agreement. Any reference in this Agreement to a provision of a statute, rule or regulation will also include any successor provision thereto. 

17. Board Membership. At each annual meeting of the Company’s stockholders prior to the Termination Date, the Company will
nominate Executive to serve as a member of the Board. Executive’s service as a member of the Board will be subject to any required stockholder approval. Upon the termination of Executive’s employment for any reason, unless otherwise
requested by the Board, Executive agrees to resign from the Board (and all other positions held at the Company and its affiliates), and Executive, at the Board’s request, will execute any documents necessary to reflect his resignation.

 18. Indemnification and D&O Insurance. Executive will be provided indemnification to the maximum extent permitted
by the Company’s and its subsidiaries’ and affiliates’ Articles of Incorporation or Bylaws, including, if applicable, any directors and officers insurance policies, with such indemnification to be on terms determined by the Board or
any of its committees, but on terms no less favorable than provided to any other Company executive officer or director and subject to the terms of any separate written indemnification agreement. 

19. Employee Benefits. Executive will be eligible to participate in the Company employee benefit plans, policies and arrangements
that are applicable to other executive officers of the Company, as such plans, policies and arrangements may exist from time to time and on terms at least as favorable as provided to any other executive officer of the Company. 

20. No Duplication of Benefits. The benefits provided to Executive in this Agreement shall offset substantially similar benefits
provided to Executive pursuant to another Company policy, plan or agreement (including without limitation the Symantec Corporation Executive Severance Plan and the Symantec Corporation Executive Retention Plan). 

  
 17 

 21. Survival. Notwithstanding any provision of this Agreement to the contrary, the
parties’ respective rights and obligations under Sections 2 and 3, will survive any termination or expiration of this Agreement or the termination of the Executive’s employment for any reason whatsoever. 

22. Counterparts. This Agreement may be executed in one or more counterparts, each of which will be deemed to be an original but
all of which together will constitute one and the same agreement. 

  
 18 

 IN WITNESS WHEREOF, the parties have caused this Agreement to be duly executed and delivered as of the date
first above written. 
  

			
	SYMANTEC CORPORATION
		
	By:	 	 /S/ SCOTT C. TAYLOR

	Name: Scott C. Taylor
	Title: Executive Vice President, General Counsel and Secretary
	
	EXECUTIVE
	
	/S/ STEVE BENNETT
	Steve Bennett

  

  
 19 

 Annex A 
 RELEASE OF CLAIMS 
 This Release of Claims (“Agreement”) is made
by and between Symantec Corporation (“Symantec”) and Steve Bennett. 
 WHEREAS, you have agreed to enter into a
release of claims in favor of Symantec upon certain events specified in the Executive Employment Agreement by and between Symantec and you; 
 NOW, THEREFORE, in consideration of the mutual promises made herein, Symantec and you agree as follows: 
 1. Termination Date. This means the last day of your employment with Symantec. 
 2.
Acknowledgement of Payment of Wages. You acknowledge that Symantec has paid you all accrued wages, salary, bonuses, accrued but unused vacation pay and any similar payment due and owing, with the exception of the payments and benefits owed to you
under the Executive Employment Agreement and/or under any equity-based compensation awards. 
 3. Confidential Information. You hereby
acknowledge that you are bound by all confidentiality agreements that you entered into with Symantec and/or any and all past and current parent, subsidiary, related, acquired and affiliated companies, predecessors and successors thereto (which
agreements are incorporated herein by this reference), that as a result of your employment you have had access to the Confidential Information (as defined in such agreement(s)), that you will hold all such Confidential Information in strictest
confidence and that you may not make any use of such Confidential Information on behalf of any third party. You further confirm that within five business days following the Termination Date you will deliver to Symantec all documents and data of any
nature containing or pertaining to such Confidential Information and that you will not take with you any such documents or data or any reproduction thereof. 
 4. Release and Waiver of All Claims. You waive any limitation on this release under California Civil Code Section 1542 which provides that a general release does not extend to claims which a person
does not know or suspect to exist in his favor at the time of executing the release which, if known, must have materially affected his/her decision to grant the release. In consideration of the benefits provided in this Agreement, you release
Symantec, and any and all past, current and future parent, subsidiary, related and affiliated companies, predecessors and successors thereto, as well as their officers, directors, shareholders, agents, employees, affiliates, representatives,
attorneys, insurers, successors and assigns, from any and all claims, liability, damages or causes of action whatsoever, whether known or unknown, which exist or may in the future exist arising from or relating to events, acts or omissions on or
before the Effective Date of this Agreement, other than those rights which as a matter of law cannot be waived.  

  
 20 

 You understand and acknowledge that this release includes, but is not limited to any claim for
reinstatement, re-employment, damages, attorney fees, stock options, bonuses or additional compensation in any form, and any claim, including but not limited to those arising under tort, contract and local, state or federal statute, including but
not limited to Title VII of the Civil Rights Act of 1964, the Civil Rights Act of 1991, the Post Civil War Civil Rights Act (42 U.S.C. 1981-88), the Equal Pay Act, the Age Discrimination in Employment Act, the Americans with Disabilities Act, the
Vietnam Era Veterans Readjustment Assistance Act, the Fair Labor Standards Act, the Family Medical Leave Act of 1993, the Uniformed Services Employment and Re-employment Rights Act, the Employee Retirement Income Security Act of 1974, and the civil
rights, employment, and labor laws of any state and any regulation under such authorities relating to your employment or association with Symantec or the termination of that relationship. 
 You also acknowledge that you are waiving and releasing any rights you may have under the Age Discrimination in Employment Act (ADEA) and that this waiver and release is knowing and voluntary. You
acknowledge that (1) you have been, and hereby are, advised in writing to consult with an attorney prior to executing this Agreement; (2) as consideration for executing this Agreement, you have received additional benefits and compensation
of value to which you would otherwise not be entitled, and (3) by signing this Agreement, you will not waive rights or claims under the Act which may arise after the execution of this Agreement; and (4) you have twenty-one
(21) calendar days within which to consider this Agreement and in the event you sign the Agreement prior to 21days, you do so voluntarily. Once you have accepted the terms of this Agreement, you will have an additional seven (7) calendar
days in which to revoke such acceptance. To revoke, you must send a written statement of revocation to the Vice President of Human Resources. If you revoke within seven (7) days, you will receive no benefits under this Agreement. In the event
you do not exercise your right to revoke this Agreement, the Agreement shall become effective on the date immediately following the seven-day (7) waiting period described above. 
 This release does not waive any rights you may have under any directors and officers insurance or indemnity provision, agreement or policy in effect as of the Termination Date, nor does it affect vested
rights you may have under any equity-based compensation plan, retirement plan, 401(k) plan or other benefits plan. 
 5. No Pending or Future
Lawsuits. You represent that you have no lawsuits, claims, or actions pending in your name or on behalf of any other person or entity, against Symantec or any other person or entity referred to herein. You also represent that you do not intend to
bring any claims on your own behalf or on behalf of any other person or entity against Symantec or any other person or entity referred to herein. 
 6. Resignation from Board. You agree that you will offer your resignation from the Board of Directors effective upon your Termination Date. The Board may accept or reject your offer of resignation within
its sole and absolute discretion. 
 7. Non disparagement. You agree that you will not, whether orally or in writing, make any disparaging
statements or comments, either as fact or as opinion, about Symantec or its products and services, business, technologies, market position, agents, representatives, directors, officers, shareholders, attorneys, employees, vendors, affiliates,
successors or assigns, or any person acting by, through, under or in concert with any of them. 

  
 21 

 8. Additional Terms 
  

	A.	Legal and Equitable Remedies. You agree that Symantec shall have the right to enforce this Agreement and any of its provisions by injunction, specific performance or
other equitable relief without prejudice to any other rights or remedies Symantec may have at law or in equity for breach of this Agreement. 

  

	B.	Attorney’s Fees. If any action at law or in equity is brought to enforce the terms of this Agreement, the prevailing party shall be entitled to recover from the
other party its reasonable attorneys’ fees, costs and expenses at trial or arbitration and any appeal therefrom, in addition to any other relief to which such prevailing party may be entitled. 

 

	C.	Non-Disclosure. You agree to keep the contents, terms and conditions of this Agreement confidential; provided, however that you may disclose this Agreement with your
spouse, attorneys, and accountants, or pursuant to subpoena or court order. Any breach of this non-disclosure paragraph is a material breach of this Agreement. 

 

	D.	No Admission of Liability. This Agreement is not, and the parties shall not represent or construe this Agreement, as an admission or evidence of any wrongdoing or
liability on the part of Symantec, its officers, shareholders, directors, employees, subsidiaries, affiliates, divisions, successors or assigns. Neither party shall attempt to admit this Agreement into evidence for any purpose in any proceeding
except in a proceeding to construe or enforce the terms of this Agreement. 

  

	E.	Entire Agreement. This Agreement along with the Executive Employment Agreement, the Intellectual Property and Confidentiality Agreement, and your written equity award
agreements with Symantec, constitutes the entire agreement between you and Symantec with respect to your separation from Symantec and supersedes all prior negotiations and agreements, whether written or oral, relating to its subject matter.

  

	F.	Modification/Successors. This Agreement may not be altered, amended, modified, or otherwise changed in any respect except by another written agreement that specifically
refers to this Agreement, and that is duly executed by you and an authorized representative of Symantec. This Agreement shall be binding upon your heirs, executors, administrators and other legal representatives and may be assigned and enforced by
Symantec, its successors and assigns. 

  

	G.	Severability. The provisions of this Agreement are severable. If any provision of this Agreement or its application is held invalid, the invalidity shall not affect
other obligations, provisions, or applications of this Agreement that can be given effect without the invalid obligations, provisions, or applications. 

  

	H.	Waiver. The failure of either party to demand strict performance of any provision of this Agreement shall not constitute a waiver of any provision, term, covenant, or
condition of this agreement or of the right to demand strict performance in the future. 

  
 22 

	I.	Governing Law and Jurisdiction. This Agreement shall be interpreted and enforced in accordance with the laws of the State of California. The exclusive jurisdiction for
any action to interpret or enforce this Agreement shall be the State of California. 

  

	J.	Counterparts. This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which together shall constitute one and same
instrument. 

  

	K.	Voluntary Execution of Agreement. This Agreement is executed voluntarily and without any duress or undue influence on the part of the Parties hereto, with the full
intent of releasing all claims. You acknowledge that: 

  

	 	a.	You have read this Agreement; 

  

	 	b.	You understand the terms and consequences of this Agreement and the releases it contains; 

 

	 	c.	You have been advised to consult with an attorney prior to executing this Agreement 

 

	 	d.	You knowingly and voluntarily agree to all the terms in this Agreement and; 

 

	 	e.	You knowingly and voluntarily intend to be bound by this Agreement. 

  

									
	Sign:	 	  
	 		 	Dated:	 	
				
	Symantec Corporation	 		 		 	
	By	 	  
	 		 	Dated:	 	

  
 23

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00207-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00207-of-00352.parquet"}]]